PharmaBlock Sciences (Nanjing), Inc.

SZSE:300725 Stock Report

Market Cap: CN¥6.9b

PharmaBlock Sciences (Nanjing) Management

Management criteria checks 2/4

PharmaBlock Sciences (Nanjing)'s CEO is Minmin Yang, appointed in Apr 2023, has a tenure of 1.5 years. directly owns 20.82% of the company’s shares, worth CN¥1.44B. The average tenure of the management team and the board of directors is 1.6 years and 2.9 years respectively.

Key information

Minmin Yang

Chief executive officer

CN¥860.0k

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership20.8%
Management average tenure1.6yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

Sep 30
PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Aug 23
PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

Jul 31
We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

Jun 12
PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Apr 21
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

Mar 07
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

CEO

Minmin Yang (52 yo)

1.5yrs

Tenure

CN¥860,000

Compensation

Dr. Minmin Yang, Ph D., serves as Director of Myrobalan Therapeutics Holding, Inc. He is Co-Founder at PharmaBlock Sciences (Nanjing), Inc and has been its Chairman since December 2014. Dr. Yang serves as...


Leadership Team

NamePositionTenureCompensationOwnership
Minmin Yang
Co-Founder1.5yrsCN¥860.00k20.82%
CN¥ 1.4b
Wu Yifei
Secretary3.3yrsCN¥1.05mno data
Shijie Zhang
Chief Technology Officer1.8yrsCN¥2.29m0.020%
CN¥ 1.4m
Jing Li
Sr. VP of Process Chemistry & President of PharmaBlock (USA)no dataCN¥1.97mno data
Shuhai Zhao
Co-founder & Chief Scientific Officerno dataCN¥344.50kno data
David Chen
Executive VPless than a yearno datano data
Dezhi Sha
Sr. VP of Process Technology & Manufacturingno datano datano data

1.6yrs

Average Tenure

52yo

Average Age

Experienced Management: 300725's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Minmin Yang
Co-Founder9.8yrsCN¥860.00k20.82%
CN¥ 1.4b
Juanjuan Wu
Non-Independent Director1.4yrsCN¥520.00kno data
Shanbao Yu
Non-Employee Supervisor2.9yrsCN¥747.60kno data
Shuqiang Zhang
Non-Employee Supervisor2.9yrsno datano data
Jingwei Zhu
Director2.9yrsCN¥1.02mno data
Weizheng Xu
Independent Director2.9yrsCN¥80.00kno data
Yunbin Gao
Independent Director2.9yrsCN¥80.00kno data
Li Jin
Independent Director2.9yrsCN¥80.00kno data

2.9yrs

Average Tenure

49yo

Average Age

Experienced Board: 300725's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.